HHS Awards About $2.27B in Ryan White Grants
Although recipients of Ryan White HIV/AIDS program grants received about $70 million less in federal funding in fiscal year (FY) 2019 compared to FY 2018, awardees still received about $2.27 billion in awards this year under the various parts of the program, the Department of Health and Human Services (HHS) said recently.
The grant funds, administered by the Health Resources and Services Administration (HRSA), support a comprehensive system of HIV primary medical care, medication and essential support services to more than 500,000 people with HIV in the U.S. The program awards grants to states, cities, counties and local community-based organizations to provide care and treatment services to low-income people living with HIV to improve health outcomes and reduce HIV transmission among hard-to-reach populations.
In 2017, approximately 86% of Ryan White HIV/AIDS Program clients who received HIV medical care were virally suppressed, up from 69% in 2010. “Ryan White HIV/AIDS program clients, despite often very challenging circumstances, have a viral suppression rate that far exceeds the national average,” said HHS Secretary Alex Azar. “The successes of the Ryan White HIV/AIDS Program are in part thanks to how the program cares for the needs of the whole person, including nonhealth factors.”
Individuals with HIV who take HIV medication daily as prescribed and who reach and maintain an undetectable viral load have effectively no risk of sexually transmitting the virus to a partner who does not have HIV, according to HRSA. Added HRSA Acting Administrator Tom Engels, “These grants will help ensure that Americans with HIV/AIDS have access to life-saving care and treatment needed to improve their health quality and medical outcomes.”
The Ryan White HIV/AIDS program, authorized and funded under Title XXVI of the Public Health Service Act (Pub. L. 78-410), as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009 (Pub. L. 111-78), is divided into five parts.
Under Part A of the program (CFDA 93.914), HRSA awarded about $628.3 million to 24 eligible metropolitan areas and 28 transitional grant areas with the highest number of people with HIV and AIDS to provide core medical and support services for these individuals.
Part A recipients are required to determine not only the size and demographics of HIV-infected individuals, but also those individuals who are unaware of their HIV status. One-third of Part A supplemental grants are to be based on the area’s ability to demonstrate its success in identifying individuals with HIV who are unaware of their status and bringing attention to their status.
HRSA also awarded about $1.3 billion to 59 states and territories under Part B of the program (CFDA 93.917) to improve the quality, availability and organization of core HIV health care and support services and for the AIDS Drug Assistance Program. In addition, 16 states received Part B Emerging Community grants based on the number of AIDS cases identified over the most recent five-year period, and 31 states and territories were also awarded some $11.2 million in Part B Minority AIDS Initiative grants.
The specific allowable services funded by each state or territory under Part B are determined at the state or territory level based on needs assessment and available funding. Core medical services include outpatient and ambulatory health services, AIDS pharmaceutical assistance, oral health care, early intervention services, health insurance premium and cost-sharing assistance, home health care, medical nutrition therapy, hospice services, home and community-based health services, mental health services, outpatient substance abuse care and medical case management, including treatment-adherence services. All Part B recipients and subrecipients must vigorously pursue enrollment in available health coverage options for eligible clients.
HRSA awarded about $181.8 million to 349 local community-based organizations under Part C Early Intervention Services (CFDA 93.918) of the Ryan White HIV/AIDS program to provide core medical and support services to people with HIV.
Additionally, 76 organizations were awarded some $10.2 million in Part C Capacity Development grants, which provide funding to assist public and nonprofit entities in their efforts to strengthen their organizational infrastructure and to increase their capacity to develop, enhance or expand access to high-quality HIV primary healthcare services for people living with HIV or who are at risk of infection in underserved or rural communities.
Also, HRSA provided about $69.7 million to 115 local community-based organizations under Part D of the program (CFDA 93.153) to provide family-centered comprehensive HIV care and treatment for low-income women, infants, children and youth with HIV. This funding aims to strengthen organizational capacity to respond to the changing health care landscape, and to increase capacity to develop, enhance or expand access to high-quality family-centered care services for these individuals.
Under Part F of the Ryan White HIV/AIDS program (CFDA 93.924), HRSA awarded about $66.7 million to support clinical training, oral health services, quality improvement and the development of innovative models of care through several different programs. It awarded some $9.1 million to 48 recipients through the Dental Reimbursement Program, and about $3.5 million to 12 recipients through the Community-Based Dental Partnership Program. Also under Part F, HRSA issued about $29.2 million through 14 grants and cooperative agreements under the AIDS Education and Training Centers program to support education and training of health care professionals, which includes a network of eight regional and two national centers.
In addition, HRSA awarded $25 million through the Ryan White HIV/AIDS Program Special Projects of National Significance program under Part F, which supports the development of innovative models of care, informing evidence-based interventions for populations with HIV who are significantly difficult to engage, retain in care, and reach, and sustain viral suppression with antiretroviral therapy.
For More Information
More information about the Ryan White HIV/AIDS program, with links to recipients of FY 2019 awards under the various parts, is available at hab.hrsa.gov.